Meiji Yasuda Asset Management Co Ltd. raised its holdings in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 4.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 16,649 shares of the real estate investment trust’s stock after buying an additional 700 shares during the quarter. Meiji Yasuda Asset Management Co Ltd.’s holdings in Healthpeak Properties were worth $337,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its stake in Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after acquiring an additional 4,056,931 shares during the last quarter. Thrivent Financial for Lutherans purchased a new position in shares of Healthpeak Properties in the third quarter worth about $1,880,000. M&T Bank Corp acquired a new stake in shares of Healthpeak Properties during the third quarter worth about $22,995,000. HighTower Advisors LLC purchased a new position in Healthpeak Properties during the 3rd quarter worth approximately $4,141,000. Finally, Diamant Asset Management Inc. acquired a new stake in Healthpeak Properties during the 3rd quarter valued at approximately $564,000. Institutional investors and hedge funds own 93.57% of the company’s stock.
Healthpeak Properties Stock Down 0.1 %
DOC opened at $20.20 on Friday. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a twelve month low of $17.80 and a twelve month high of $23.26. The company has a market cap of $14.13 billion, a PE ratio of 57.70, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. The company has a 50-day moving average price of $20.23 and a 200 day moving average price of $21.11.
Healthpeak Properties Increases Dividend
Wall Street Analysts Forecast Growth
DOC has been the subject of a number of research reports. Scotiabank decreased their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research report on Friday, February 28th. Wells Fargo & Company dropped their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. Robert W. Baird decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Tuesday, February 11th. StockNews.com raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Saturday, March 22nd. Finally, Mizuho decreased their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. Four equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.92.
Get Our Latest Stock Analysis on DOC
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- What is the Hang Seng index?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- What is the NASDAQ Stock Exchange?
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to trade penny stocks: A step-by-step guide
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.